Leo Wealth LLC Buys 1,487 Shares of Sanofi (NASDAQ:SNY)

Leo Wealth LLC boosted its stake in shares of Sanofi (NASDAQ:SNY) by 5.9% during the fourth quarter, Holdings Channel.com reports. The fund owned 26,669 shares of the company’s stock after acquiring an additional 1,487 shares during the period. Leo Wealth LLC’s holdings in Sanofi were worth $1,286,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in SNY. Jennison Associates LLC boosted its position in shares of Sanofi by 938.0% during the 3rd quarter. Jennison Associates LLC now owns 1,904,445 shares of the company’s stock worth $109,753,000 after acquiring an additional 1,720,972 shares in the last quarter. Thrivent Financial for Lutherans lifted its stake in Sanofi by 28,890.2% during the third quarter. Thrivent Financial for Lutherans now owns 1,429,219 shares of the company’s stock worth $82,366,000 after purchasing an additional 1,424,289 shares during the last quarter. DAVENPORT & Co LLC boosted its holdings in shares of Sanofi by 40.7% in the 4th quarter. DAVENPORT & Co LLC now owns 2,295,569 shares of the company’s stock valued at $110,715,000 after purchasing an additional 664,455 shares in the last quarter. JPMorgan Chase & Co. increased its stake in shares of Sanofi by 20.9% in the 3rd quarter. JPMorgan Chase & Co. now owns 2,310,809 shares of the company’s stock valued at $133,172,000 after purchasing an additional 399,301 shares during the last quarter. Finally, Franklin Resources Inc. raised its holdings in shares of Sanofi by 13.1% during the 3rd quarter. Franklin Resources Inc. now owns 3,407,452 shares of the company’s stock worth $208,106,000 after buying an additional 395,744 shares in the last quarter. 14.04% of the stock is owned by institutional investors and hedge funds.

Sanofi Trading Down 1.2 %

Shares of SNY stock opened at $52.87 on Friday. The company has a quick ratio of 0.74, a current ratio of 1.46 and a debt-to-equity ratio of 0.15. The firm has a market capitalization of $134.18 billion, a P/E ratio of 21.23, a P/E/G ratio of 1.26 and a beta of 0.57. Sanofi has a twelve month low of $45.22 and a twelve month high of $58.97. The stock’s fifty day simple moving average is $49.62 and its 200 day simple moving average is $52.35.

Sanofi (NASDAQ:SNY) last released its quarterly earnings results on Thursday, January 30th. The company reported $0.70 earnings per share for the quarter, hitting the consensus estimate of $0.70. Sanofi had a return on equity of 25.58% and a net margin of 12.77%. As a group, sell-side analysts predict that Sanofi will post 4.34 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on SNY shares. StockNews.com lowered Sanofi from a “buy” rating to a “hold” rating in a research note on Thursday, December 12th. Deutsche Bank Aktiengesellschaft upgraded shares of Sanofi from a “sell” rating to a “hold” rating in a research note on Thursday, January 30th. Finally, Sanford C. Bernstein upgraded shares of Sanofi to a “strong-buy” rating in a research report on Thursday, January 30th. Two analysts have rated the stock with a hold rating, one has given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $60.00.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.